{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T21:03:40Z","timestamp":1773090220740,"version":"3.50.1"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,2]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Transepidermal clearance of altered collagen and excessive excretion of keratin are characteristics of a rare cutaneous disorder known as reactive perforating collagenosis (RPC). There are different forms of RPC; however, the acquired form is the most prevalent and inherited. Reactive perforating collagenosis is rarely described in autoimmune rheumatic diseases; instead, it is typically linked to systemic conditions such as renal failure or hepatic disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A 31-year-old Saudi female patient who was initially diagnosed with undifferentiated connective tissue disease. She developed RPC with a severe diffuse itchy skin rash with numerous papules and nodules with central hyperkeratotic plugs over the lower limb, upper limb, and face.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The patient tested positive for antinuclear antibody; however, a year later, patient developed Raynaud\u2019s phenomenon, oral and nasal ulcers, malar rash, fatigue, and lupus rash around her eyes, and systemic lupus erythematosus was diagnosed clinically. The patient was treated for reactive perforating collagenosis with systemic antihistamines (diphenhydramine 50\u2009mg orally twice daily), topical steroid cream (betamethasone dipropionate cream), and oral isotretinoin (20\u2009mg daily). The patient was advised to undergo phototherapy. A year later, she presented with symptoms of systemic lupus erythematosus and started taking oral hydroxychloroquine 200\u2009mg twice daily for systemic lupus erythematosus. The patient is listed on follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Variable skin rash can mimic systemic lupus erythematosus and vasculitis. Therefore, reactive perforating collagenosis is a skin condition that requires high clinical suspension for diagnosis, and it might be challenging to determine whether it is an association or a complication. Furthermore, the timing of the skin biopsy may be crucial for the diagnosis of reactive perforating collagenosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000032138","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T16:04:30Z","timestamp":1670515470000},"page":"e32138","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Reactive perforating collagenosis and systemic lupus erythematosus: A rare case report"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8495-9064","authenticated-orcid":false,"given":"Fahidah","family":"Alenzi","sequence":"first","affiliation":[{"name":"Clinical Sciences Department, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0190-9622(94)70065-6","article-title":"Acquired reactive perforating collagenosis: Report of six cases and review of the literature.","volume":"30","author":"Faver","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"R2-20250504","first-page":"297","article-title":"Acquired reactive perforating collagenosis.","volume":"46","author":"Yang","year":"2017","journal-title":"J Clin Dermatol"},{"key":"R3-20250504","article-title":"Acquired reactive perforating collagenosis: a case report.","volume":"13","author":"Eljazouly","year":"2021","journal-title":"Cureus"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4103\/2249-4863.154678","article-title":"Kyrle\u2019s disease in a patient of diabetes mellitus and chronic renal failure on dialysis.","volume":"4","author":"Nair","year":"2015","journal-title":"J Fam Med Prim Care"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/0971-4065.97127","article-title":"A prospective study of cutaneous abnormalities in patients with chronic kidney disease.","volume":"22","author":"Thomas","year":"2012","journal-title":"Indian J Nephrol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/0019-5154.41654","article-title":"Rare presentation of Kyrle\u2019s disease in siblings.","volume":"53","author":"Viswanathan","year":"2008","journal-title":"Indian J Dermatol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-4632.2004.01988.x","article-title":"Perforating disorder caused by salt-water application and its experimental induction.","volume":"44","author":"Lee","year":"2005","journal-title":"Int J Dermatol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/1346-8138.13357","article-title":"Acquired reactive perforating collagenosis associated with systemic lupus erythematosus.","volume":"43","author":"Ohashi","year":"2016","journal-title":"J Dermatol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4161\/derm.1.4.9555","article-title":"Leucocytoclastic vasculitis associated with acquired reactive perforating collagenosis.","volume":"1","author":"M\u00fcller","year":"2009","journal-title":"Dermatoendocrinol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1365-2133.2002.04550.x","article-title":"Expression of the 67-kDa elastin receptor in perforating skin disorders.","volume":"146","author":"Fujimoto","year":"2002","journal-title":"Br J Dermatol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1346-8138.2011.01210.x","article-title":"Acquired reactive perforating collagenosis in dermatomyositis.","volume":"38","author":"Amano","year":"2011","journal-title":"J Dermatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:08:07Z","timestamp":1746331687000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":11,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032138","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,2]]}}}